Mueller, Andreas; Weyerhaeuser, Patrick; Berte, Nancy et al.
Concurrent Activation of Both Survival-Promoting and Death-Inducing Signaling by Chloroquine in Glioblastoma Stem Cells: Implications for Potential Risks and Benefits of Using Chloroquine as RadiosensitizerCELLS. Bd. 12. H. 9. 2023
Rotheneeder, Matthia; Stakyte, Kristina; van de Logt, Erik et al.
Cryo-EM structure of the Mre11-Rad50-Nbs1 complex reveals the molecular mechanism of scaffolding functionsMOLECULAR CELL. Bd. 83. H. 2. 2023 S. 167-+
Fahrer, Joerg; Christmann, Markus
DNA Alkylation Damage by Nitrosamines and Relevant DNA Repair PathwaysINTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. Bd. 24. H. 5. 2023
Stanfill, Stephen B.; Hecht, Stephen S.; Joerger, Andreas C. et al.
From cultivation to cancer: formation of N-nitrosamines and other carcinogens in smokeless tobacco and their mutagenic implicationsCRITICAL REVIEWS IN TOXICOLOGY. Bd. 53. H. 10. 2023 S. 658-701
Zeyn, Yanira; Hausmann, Kristin; Halilovic, Melisa et al.
Histone deacetylase inhibitors modulate hormesis in leukemic cells with mutant FMS-like tyrosine kinase-3LEUKEMIA. 2023
Rashan, Luay. J. J.; Oezenver, Nadire; Boulos, Joelle. C. C. et al.
Molecular Modes of Action of an Aqueous <i>Nerium oleander</i> Extract in Cancer Cells In Vitro and In VivoMOLECULES. Bd. 28. H. 4. 2023
Sigismondo, Gianluca; Arseni, Lavinia; Palacio-Escat, Nicolas et al.
Multi-layered chromatin proteomics identifies cell vulnerabilities in DNA repairNUCLEIC ACIDS RESEARCH. Bd. 51. H. 2. 2023 S. 687-711
Ashry, Ramy; Mustafa, Al-Hassan M.; Hausmann, Kristin et al.
NOXA Accentuates Apoptosis Induction by a Novel Histone Deacetylase InhibitorCANCERS. Bd. 15. H. 14. 2023
Mustafa, Al-Hassan M.; Kramer, Oliver H.
Pharmacological Modulation of the Crosstalk between Aberrant Janus Kinase Signaling and Epigenetic Modifiers of the Histone Deacetylase Family to Treat CancerPHARMACOLOGICAL REVIEWS. Bd. 75. H. 1. 2023 S. 35-61
Castven, Darko; Keggenhoff, Friederike; Stojkovic, Stojan et al.
Positive effects of PARP-1 inhibition in KRAS-mutated intrahepatic cholangiocarcinoma is mediated by CHK1 kinaseJOURNAL OF HEPATOLOGY. Bd. 78. 2023 S. S536-S537